Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
Taiwan
· Delayed Price · Currency is TWD 156.00
-0.50 (-0.32%)
Jun 11, 2025, 1:30 PM CST
TPEX:6712 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Net Income | 433.63 | 367.25 | 539.4 | 200.71 | 369.6 | -106.83 | Upgrade
|
| Depreciation & Amortization | 28.87 | 30.49 | 31.8 | 34.73 | 35.14 | 31.26 | Upgrade
|
| Other Amortization | 0.39 | 0.4 | 0.51 | 0.82 | 0.68 | 0.67 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.01 | 0.01 | - | 0 | -11.33 | 0.05 | Upgrade
|
| Loss (Gain) From Sale of Investments | -24.5 | 46.68 | -241.86 | 22.7 | -261.05 | -14.31 | Upgrade
|
| Loss (Gain) on Equity Investments | -48.68 | -52.09 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 15.6 | - | - | 0.79 | 2.14 | 4.22 | Upgrade
|
| Other Operating Activities | 45.68 | 69.34 | 63.59 | 32.04 | 26.66 | -30.4 | Upgrade
|
| Change in Accounts Receivable | -54.61 | -93.36 | -16.94 | -51.1 | -17.62 | -9.66 | Upgrade
|
| Change in Inventory | 8.95 | -10.95 | 19.22 | -31.53 | -21.28 | -20.73 | Upgrade
|
| Change in Accounts Payable | 0.54 | 1.8 | -5.74 | 14.08 | 9.96 | 3.88 | Upgrade
|
| Change in Unearned Revenue | 99.68 | 72.48 | 31.76 | 77.68 | 8.09 | 1.64 | Upgrade
|
| Change in Other Net Operating Assets | 72.33 | 8.29 | 0.01 | 18.27 | -5.29 | 1.74 | Upgrade
|
| Operating Cash Flow | 577.87 | 440.34 | 421.74 | 319.2 | 135.69 | -138.47 | Upgrade
|
| Operating Cash Flow Growth | 38.37% | 4.41% | 32.12% | 135.25% | - | - | Upgrade
|
| Capital Expenditures | -4.92 | -4.85 | -5.82 | -3.19 | -1.98 | -58.83 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 28.1 | 0.07 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.72 | -0.71 | -0.02 | -2.41 | -2.67 | -1.97 | Upgrade
|
| Investment in Securities | -348.98 | 22.76 | 64.31 | -279.19 | -316.21 | 216 | Upgrade
|
| Other Investing Activities | -41.12 | -40.67 | 3.12 | -2.52 | -4.06 | -8.5 | Upgrade
|
| Investing Cash Flow | -395.73 | -23.46 | 61.6 | -287.31 | -296.83 | 146.77 | Upgrade
|
| Long-Term Debt Repaid | - | -11.59 | -11.92 | -11.11 | -10.02 | -8.96 | Upgrade
|
| Net Debt Issued (Repaid) | -11.3 | -11.59 | -11.92 | -11.11 | -10.02 | -8.96 | Upgrade
|
| Issuance of Common Stock | 0.02 | 0.02 | 4.04 | 2.37 | 745.29 | 37.46 | Upgrade
|
| Repurchase of Common Stock | -338.83 | - | -356.35 | - | - | - | Upgrade
|
| Common Dividends Paid | -440.03 | -440.03 | -136.29 | -309.49 | - | - | Upgrade
|
| Other Financing Activities | 17.72 | -0.04 | 0.06 | -1.2 | -1.9 | 0.09 | Upgrade
|
| Financing Cash Flow | -772.43 | -451.64 | -500.47 | -319.43 | 733.36 | 28.59 | Upgrade
|
| Net Cash Flow | -590.29 | -34.77 | -17.13 | -287.53 | 572.22 | 36.89 | Upgrade
|
| Free Cash Flow | 572.95 | 435.49 | 415.92 | 316.02 | 133.7 | -197.3 | Upgrade
|
| Free Cash Flow Growth | 39.09% | 4.70% | 31.61% | 136.35% | - | - | Upgrade
|
| Free Cash Flow Margin | 60.41% | 46.63% | 54.84% | 50.36% | 30.47% | -279.48% | Upgrade
|
| Free Cash Flow Per Share | 6.45 | 4.91 | 4.61 | 3.46 | 1.47 | -2.40 | Upgrade
|
| Cash Interest Paid | 0.27 | 0.13 | 0.2 | 0.51 | 0.62 | 0.78 | Upgrade
|
| Cash Income Tax Paid | 68.56 | 68.57 | 19.66 | 31.17 | 0.04 | -0 | Upgrade
|
| Levered Free Cash Flow | 851.72 | 290.39 | 304.48 | 219.61 | 100.32 | -148.09 | Upgrade
|
| Unlevered Free Cash Flow | 851.89 | 290.47 | 304.6 | 219.92 | 100.7 | -147.6 | Upgrade
|
| Change in Net Working Capital | -553.08 | -1.89 | -67.04 | -11.81 | 5.23 | 24.76 | Upgrade
|
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.